This company seems to have been delisted
Reason: filed for bankruptcy
Last recorded trade on: June 14, 2024
Source: https://www.biopharmadive.com/news/acorda-bankruptcy-asset-sale-merz-stalking-horse/712010/
Reason: filed for bankruptcy
Last recorded trade on: June 14, 2024
Source: https://www.biopharmadive.com/news/acorda-bankruptcy-asset-sale-merz-stalking-horse/712010/
Acorda Therapeutics
ACOR
A$1.01
Share price
0.00%
Change (1 day)
-95.62%
Change (1 year)
Categories
Earnings for Acorda Therapeutics (ACOR)
Earnings in 2024 (TTM): -A$0.41 Billion
According to Acorda Therapeutics 's latest financial reports the company's current earnings are A$0.11 Billion. In 2023 the company made an earning of -A$0.41 Billion a decrease over its 2022 earnings that were of -A$8.2 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Acorda Therapeutics from 2006 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024 (TTM)  | -A$0.41 Billion | -1.22% |
| 2023 | -A$0.41 Billion | 4848.63% |
| 2022 | -A$8.2 Million | -93.25% |
| 2021 | -A$0.13 Billion | 2.52% |
| 2020 | -A$0.12 Billion | -69.45% |
| 2019 | -A$0.39 Billion | -700.62% |
| 2018 | A$64.48 M | -118.02% |
| 2017 | -A$0.36 Billion | 805.99% |
| 2016 | -A$39.51 Million | -173.88% |
| 2015 | A$53.46 M | -6.58% |
| 2014 | A$57.23 M | 20.19% |
| 2013 | A$47.62 M | 18.7% |
| 2012 | A$40.11 M | -26.54% |
| 2011 | A$54.61 M | |
| 2009 | -A$0.13 Billion | 10.65% |
| 2008 | -A$0.12 Billion | 86.17% |
| 2007 | -A$60.54 Million | 68.1% |
| 2006 | -A$36.02 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | -A$2.82 Million | -99.32% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | A$1.03 B | -348.11% | 🇺🇸 USA |
 Affimed
AFMD | -A$0.12 Billion | -71.86% | 🇩🇪 Germany |
 Sarepta Therapeutics
SRPT | -A$0.26 Billion | -39.58% | 🇺🇸 USA |